Get started
Author

Tanujaa Rajasekaran

Observed names: Rajasekaran, Tanujaa, T Rajasekaran, T. Rajasekaran, Tanujaa D/O Rajasekaran
ORCID: 0000-0001-5895-6740
Observed ORCID: 0000-0001-5895-6740
OpenAlex ID: A5085784504
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis
2019 · Aaron C. Tan, Gillianne G.Y. Lai, et al. · Lung Cancer · 121
Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer
2019 · Gillianne G.Y. Lai, Tse Hui Lim, et al. · Journal of Clinical Oncology · 117
Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor–Positive Non–Small Cell Lung Cancer
2021 · Stephanie P. L. Saw, Siqin Zhou, et al. · JAMA Network Open · 57
PDF
Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC
2020 · Aaron C. Tan, Amanda O.L. Seet, et al. · Journal of Thoracic Oncology · 48
PDF
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell‐free DNA for monitoring minimal residual disease and early detection of recurrence in early‐stage lung cancer
2024 · Aaron C. Tan, Gillianne G. Y. Lai, et al. · Cancer · 46
Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities
2021 · Khi Pin Chua, Yvonne H.F. Teng, et al. · Clinical Cancer Research · 37
Comprehensive Geriatric Assessment (CGA) based risk factors for increased caregiver burden among elderly Asian patients with cancer
2016 · Tanujaa Rajasekaran, Tira Tan, et al. · Journal of Geriatric Oncology · 30
PD-L1 Score as a Prognostic Biomarker in Asian Early-Stage EGFR-Mutated Lung Cancer
2022 · Stephanie P.L. Saw, Win Pin Ng, et al. · European Journal of Cancer · 26
PDF
Androgen receptor pathway inhibitors, prostate cancer, and older adults: a global Young International Society of Geriatric Oncology drug review
2023 · Nabiel Mir, Olivia Burke, et al. · Therapeutic Advances in Medical Oncology · 18
PDF
Clinical and Genomic Features of HER2 Exon 20 Insertion Mutations and Characterization of HER2 Expression by Immunohistochemistry in East Asian Non–Small-Cell Lung Cancer
2022 · Aaron C. Tan, Stephanie P.L. Saw, et al. · JCO Precision Oncology · 18
Identification of Comprehensive Geriatric Assessment Based Risk Factors for Malnutrition in Elderly Asian Cancer Patients
2016 · Tira Tan, Whee Sze Ong, et al. · PLoS ONE · 15
PDF
A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLC
2022 · Gillianne G.Y. Lai, Jia Chi Yeo, et al. · JTO Clinical and Research Reports · 13
PDF
Metronomic chemotherapy: A relook at its basis and rationale
2016 · Tanujaa Rajasekaran, Quan-Sing Ng, et al. · Cancer Letters · 13
P1.17-07 Neoadjuvant Gefitinib in Resectable Early Stage EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): A Window-of-Opportunity Study
2019 · A. Tan, K.P. Chua, et al. · Journal of Thoracic Oncology · 12
PDF
MA07.06 Circulating Tumor DNA for Monitoring Minimal Residual Disease and Early Detection of Recurrence in Early Stage Lung Cancer
2021 · A. Tan, G. Lai, et al. · Journal of Thoracic Oncology · 11
PDF
Pilot Trial of a Combined Oncologist-Patient-Caregiver Communication Intervention in Singapore
2019 · Chetna Malhotra, Tanujaa Rajasekaran, et al. · JCO Oncology Practice · 10
PDF
266O Combination ipilimumab and nivolumab in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC): Updated efficacy and safety analysis of NCT03097939
2020 · H-F. Kao, M-K. Ang, et al. · Annals of Oncology · 9
Far from the truth: Real‐world treatment patterns among newly diagnosed metastatic prostate cancer in the era of treatment intensification
2023 · Xinyan Yang, Yu Guang Tan, et al. · International Journal of Urology · 7
PDF
Abstract 5114: Ultra-sensitive detection of minimal residual disease (MRD) through whole genome sequencing (WGS) using an AI-based error suppression model in resected early-stage non-small cell lung cancer (NSCLC)
2022 · Aaron C. Tan, Stephanie P. Saw, et al. · Cancer Research · 7
Real‐world outcome with abiraterone acetate plus prednisone in Asian men with metastatic castrate‐resistant prostate cancer: The Singapore experience
2019 · Johan Chan, Shi Yin Yap, et al. · Asia-Pacific Journal of Clinical Oncology · 7
Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR+ non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance
2023 · Jun Ma, Sze Huey Tan, et al. · Translational Lung Cancer Research · 5
PDF
OA01.06 Randomised Phase 2 Study of Nivolumab (N) Versus Nivolumab and Ipilimumab (NI) Combination in EGFR Mutant NSCLC
2021 · G. Lai, J. Alvarez, et al. · Journal of Thoracic Oncology · 5
PDF
Real world data on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) use in advanced/metastatic non-small cell lung cancer (NSCLC) with EGFR mutations in Singapore
2018 · B. Chua, E.H. Tan, et al. · Annals of Oncology · 5
PDF
A systematic review to summarize treatment patterns, guidelines, and characteristics of patients with renal cell carcinoma in the Asia-Pacific region
2023 · Tsz Him So, Sheetal Sharma, et al. · Expert Review of Anticancer Therapy · 4
PDF
A digital self-reported G8 screening tool: A comparison study
2024 · Trina Arifin, Whee Sze Ong, et al. · Proceedings of Singapore Healthcare · 2
Works count: 63
Citation count: 652
H-index: 13
I10-index: 16
Year
Topic
Type